Your browser doesn't support javascript.
loading
Ectopic miR-125a Expression Induces Long-Term Repopulating Stem Cell Capacity in Mouse and Human Hematopoietic Progenitors.
Wojtowicz, Edyta E; Lechman, Eric R; Hermans, Karin G; Schoof, Erwin M; Wienholds, Erno; Isserlin, Ruth; van Veelen, Peter A; Broekhuis, Mathilde J C; Janssen, George M C; Trotman-Grant, Aaron; Dobson, Stephanie M; Krivdova, Gabriela; Elzinga, Jantje; Kennedy, James; Gan, Olga I; Sinha, Ankit; Ignatchenko, Vladimir; Kislinger, Thomas; Dethmers-Ausema, Bertien; Weersing, Ellen; Alemdehy, Mir Farshid; de Looper, Hans W J; Bader, Gary D; Ritsema, Martha; Erkeland, Stefan J; Bystrykh, Leonid V; Dick, John E; de Haan, Gerald.
Affiliation
  • Wojtowicz EE; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Lechman ER; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Hermans KG; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Schoof EM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Wienholds E; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Isserlin R; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.
  • van Veelen PA; Departments of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
  • Broekhuis MJ; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Janssen GM; Departments of Immunohematology and Blood Transfusion, Leiden University Medical Center, 2333 ZA Leiden, the Netherlands.
  • Trotman-Grant A; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Dobson SM; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Krivdova G; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada.
  • Elzinga J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Kennedy J; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Gan OI; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada.
  • Sinha A; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Ignatchenko V; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Kislinger T; Department of Medical Biophysics, University of Toronto, Toronto, ON M5G 1L7, Canada.
  • Dethmers-Ausema B; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Weersing E; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Alemdehy MF; Department of Hematology, Erasmus University Medical Center Cancer Institute, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
  • de Looper HW; Department of Hematology, Erasmus University Medical Center Cancer Institute, Wytemaweg 80, 3015 CN Rotterdam, the Netherlands.
  • Bader GD; The Donnelly Centre, University of Toronto, Toronto, ON M5S 3E1, Canada.
  • Ritsema M; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Erkeland SJ; Department of Immunology, Erasmus University Medical Center, Wytemaweg 80, 3015CN Rotterdam, the Netherlands.
  • Bystrykh LV; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands.
  • Dick JE; Princess Margaret Cancer Centre, University Health Network, Toronto, ON M5G 1L7, Canada; Department of Molecular Genetics, University of Toronto, Toronto, ON M5S 1A8, Canada. Electronic address: jdick@uhnres.utoronto.ca.
  • de Haan G; Laboratory of Ageing Biology and Stem Cells, European Research Institute for the Biology of Ageing, University Medical Centre Groningen, University of Groningen, Antonius Deusinglaan 1, 9700 AV Groningen, the Netherlands. Electronic address: g.de.haan@umcg.nl.
Cell Stem Cell ; 19(3): 383-96, 2016 09 01.
Article in En | MEDLINE | ID: mdl-27424784
ABSTRACT
Umbilical cord blood (CB) is a convenient and broadly used source of hematopoietic stem cells (HSCs) for allogeneic stem cell transplantation. However, limiting numbers of HSCs remain a major constraint for its clinical application. Although one feasible option would be to expand HSCs to improve therapeutic outcome, available protocols and the molecular mechanisms governing the self-renewal of HSCs are unclear. Here, we show that ectopic expression of a single microRNA (miRNA), miR-125a, in purified murine and human multipotent progenitors (MPPs) resulted in increased self-renewal and robust long-term multi-lineage repopulation in transplanted recipient mice. Using quantitative proteomics and western blot analysis, we identified a restricted set of miR-125a targets involved in conferring long-term repopulating capacity to MPPs in humans and mice. Our findings offer the innovative potential to use MPPs with enhanced self-renewal activity to augment limited sources of HSCs to improve clinical protocols.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Gene Expression Regulation / MicroRNAs Type of study: Guideline / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cell Stem Cell Year: 2016 Document type: Article Affiliation country: Netherlands

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hematopoietic Stem Cells / Gene Expression Regulation / MicroRNAs Type of study: Guideline / Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Cell Stem Cell Year: 2016 Document type: Article Affiliation country: Netherlands